SCHEMBL7987219

SCHEMBL7987219

O=c1[nH]c(-c2ccccc2)nc2ncn(Cc3ccccc3F)c12

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
KMT2A Q03164 4/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 3/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
MAPT P10636 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
ROCK2 O75116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986753 0.93 TNKS (0.43) ALDH1A1SMN1; SMN2KMT2ALMNATP53
SCHEMBL7991414 0.92 GRIA1 (0.42) ALDH1A1SMN1; SMN2KMT2ALMNATP53
SCHEMBL7988742 0.90 LMNA (0.42) ALDH1A1SMN1; SMN2KMT2ALMNATP53
SCHEMBL7985420 0.89 TP53 (0.42) ALDH1A1SMN1; SMN2KMT2ALMNATP53
SCHEMBL7985116 0.89 HPGD (0.44) ALDH1A1SMN1; SMN2KMT2ALMNATP53
SCHEMBL7984677 0.88 TP53 (0.41) ALDH1A1SMN1; SMN2KMT2ALMNATP53
SCHEMBL7974198 0.88 LMNA (0.41) ALDH1A1SMN1; SMN2KMT2ALMNATP53
SCHEMBL7973916 0.88 LMNA (0.43) ALDH1A1SMN1; SMN2KMT2ALMNATP53
SCHEMBL7984786 0.86 SMN1; SMN2 (0.45) ALDH1A1SMN1; SMN2KMT2ATP53POLB
SCHEMBL7974079 0.86 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2KMT2ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed